Home / Investors Information / EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress Read more about EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site Read more about EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York Read more about First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida Read more about First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida EDAP Announces Results of World's First Focal HIFU Trial Read more about EDAP Announces Results of World's First Focal HIFU Trial EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan Read more about EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center Read more about EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device Read more about EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Read more about EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress Read more about Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress Pagination First page « First Previous page ‹ Previous … Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Page 26 Page 27 … Next page Next › Last page Last » Subscribe to
EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress Read more about EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress
EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site Read more about EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site
First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York Read more about First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York
First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida Read more about First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida
EDAP Announces Results of World's First Focal HIFU Trial Read more about EDAP Announces Results of World's First Focal HIFU Trial
EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan Read more about EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan
EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center Read more about EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center
EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device Read more about EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device
EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Read more about EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California
Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress Read more about Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress
